Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19
NCT04716088 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36
Last updated 2021-01-22
Summary
Physicians, nurses and hospital attendants currently working at the University Clinic of Respiratory and Allergic Diseases Golnik were invited to participate in the pilot study. Nasopharyngeal swabs were obtained three times per week for two consecutive weeks and tested with a point-of-care rapid antigen test and reverse transcription polymerase chain reaction (RT-PCR). In addition, serum samples were obtained at the beginning of the study and 2 weeks after last swab was obtained in order to evaluate the serological status of participating health care workers.
Conditions
- SARS-CoV-2 Rapid Antigen Test
Interventions
- DIAGNOSTIC_TEST
-
Rapid antigen test for SARS CoV2
Defining diagnostic performance of repeated testing regimen in hospital setting
Sponsors & Collaborators
-
Insitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana
collaborator UNKNOWN -
The University Clinic of Pulmonary and Allergic Diseases Golnik
lead OTHER
Principal Investigators
-
Mihaela Zidarn, MD PhD · Klinika Golnik
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-18
- Primary Completion
- 2020-12-02
- Completion
- 2020-12-22
Countries
- Slovenia
Study Locations
More Related Trials
-
COVID-19 Vaccination AZV 2021-2023
NCT05589233 ·Status: COMPLETED
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.
NCT03171350 ·Status: COMPLETED ·Phase: NA
-
SARS-CoV-2 Infection Among Healthcare Workers
NCT05680896 ·Status: UNKNOWN
-
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis
NCT03693495 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of Antibody Tests for COVID-19
NCT04360954 ·Status: COMPLETED
-
Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.
NCT06057025 ·Status: UNKNOWN ·Phase: PHASE3
-
Feasibility and Usability of COVID-19 Antigen RDTs in Uganda
NCT05630300 ·Status: COMPLETED ·Phase: NA
-
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
NCT06174649 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)
NCT05506618 ·Status: UNKNOWN ·Phase: NA
-
Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.
NCT04402827 ·Status: COMPLETED
-
COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
NCT04318314 ·Status: UNKNOWN
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
NCT00778388 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA)
NCT00846105 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers
NCT04681001 ·Status: COMPLETED ·Phase: NA
-
Preview Rapid Strep A Test Method Comparison Study
NCT03907449 ·Status: SUSPENDED
-
Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites
NCT05769803 ·Status: UNKNOWN ·Phase: NA
-
Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection
NCT04339426 ·Status: TERMINATED ·Phase: PHASE2
-
BacLite Rapid MRSA Clinical Performance
NCT00541632 ·Status: TERMINATED
-
Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations
NCT05664919 ·Status: UNKNOWN ·Phase: NA
-
SARS-CoV-2 Infection in COVID-19 Vaccinated Patients
NCT05060939 ·Status: COMPLETED ·Phase: NA
-
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
NCT03361163 ·Status: COMPLETED ·Phase: PHASE1
-
Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers
NCT05203068 ·Status: COMPLETED ·Phase: NA
-
Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)
NCT05085522 ·Status: UNKNOWN